Parkinson's Disease Medications Quiz
45 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary mechanism of action for Amantadine in treating Parkinson's disease?

  • Direct stimulation of dopamine receptors
  • Inhibition of acetylcholinesterase
  • Release and reuptake of dopamine (correct)
  • Release and reuptake of serotonin
  • Why are anticholinergics considered less effective for treating bradykinesia in Parkinson's disease?

  • They enhance motor neuron excitability
  • They only alleviate tremor and rigidity (correct)
  • They have sedative effects that impair movement
  • They primarily target serotonin pathways
  • What is a significant side effect associated with the use of Amantadine?

  • Cognitive decline
  • Urinary retention (correct)
  • Severe hypertension
  • Severe hallucinations
  • Which statement about Rasagiline is true?

    <p>It can be used alone in early Parkinson's disease</p> Signup and view all the answers

    What condition should be avoided when prescribing Amantadine?

    <p>Renal failure</p> Signup and view all the answers

    What is the primary reason neurodegenerative diseases are often difficult to treat?

    <p>CNS neurons cannot divide or regenerate once damaged.</p> Signup and view all the answers

    Which of the following is NOT one of the cardinal motor features of Parkinson’s disease?

    <p>Loss of sensation</p> Signup and view all the answers

    Which neurotransmitter is primarily involved in regulating muscle movement in Parkinson’s disease?

    <p>Dopamine</p> Signup and view all the answers

    Which of the following describes a characteristic pathway of dopaminergic neurons?

    <p>Tuberoinfundibular pathway regulates prolactin secretion.</p> Signup and view all the answers

    What is a non-motor symptom associated with Parkinson’s disease?

    <p>Visual hallucinations</p> Signup and view all the answers

    Excessive excitotoxicity in the central nervous system is primarily caused by which substance?

    <p>Glutamate</p> Signup and view all the answers

    Which age group is primarily affected by Parkinson’s disease?

    <p>Elderly people over 65</p> Signup and view all the answers

    Which process is NOT a cause of neuronal damage in neurodegenerative diseases?

    <p>Increased neurotransmitter synthesis</p> Signup and view all the answers

    What is a common central side effect of levodopa therapy?

    <p>Dyskinesia</p> Signup and view all the answers

    Which of the following is a known peripheral side effect of levodopa?

    <p>Tachycardia</p> Signup and view all the answers

    What medication is commonly used to manage levodopa-induced nausea?

    <p>Domperidone</p> Signup and view all the answers

    Which receptor type is primarily overstimulated in the development of dyskinesia due to levodopa?

    <p>D2 receptors</p> Signup and view all the answers

    How does long-term levodopa use affect dopamine receptors in the brain?

    <p>It increases receptor sensitivity.</p> Signup and view all the answers

    What is the primary risk associated with the use of tolcapone?

    <p>Hepatotoxicity</p> Signup and view all the answers

    Which atypical antipsychotic is mentioned as being used to treat levodopa-induced psychosis?

    <p>Quetiapine</p> Signup and view all the answers

    What is the primary reason a D2 blocker like metoclopramide is not used for levodopa-induced nausea?

    <p>It crosses the blood-brain barrier.</p> Signup and view all the answers

    What characterizes Primary Parkinson’s Disease?

    <p>Degeneration of more than 80% of DA neurons</p> Signup and view all the answers

    Which of the following is a form of Secondary Parkinsonism?

    <p>Drug-induced Parkinsonism</p> Signup and view all the answers

    What is the primary goal of Parkinson's treatment?

    <p>Restore DA and reduce Ach levels</p> Signup and view all the answers

    Why does levodopa require large doses for effectiveness?

    <p>Most is converted to dopamine in the gut and liver</p> Signup and view all the answers

    How does carbidopa benefit the treatment of Parkinson’s disease?

    <p>It enhances the availability of levodopa to the CNS</p> Signup and view all the answers

    What does the presence of oxidative stress correlate with in Parkinson’s Disease?

    <p>Aging and neuron degeneration</p> Signup and view all the answers

    Which treatment specifically targets tremors and rigidity in Parkinson's disease?

    <p>Anticholinergic drugs</p> Signup and view all the answers

    What is a significant challenge in using levodopa for treatment?

    <p>It does not cross the blood-brain barrier</p> Signup and view all the answers

    What is a significant advantage of dopamine receptor agonists over levodopa?

    <p>They do not require presynaptic conversion to dopamine.</p> Signup and view all the answers

    Which of the following is an adverse effect associated with dopamine receptor agonists?

    <p>Pulmonary fibrosis with prolonged use.</p> Signup and view all the answers

    In what scenario is apomorphine predominantly used?

    <p>As a subcutaneous injection during OFF periods of L-dopa.</p> Signup and view all the answers

    Which is true about the MAOB inhibitor deprenyl?

    <p>It serves as a free radical scavenger.</p> Signup and view all the answers

    What is a potential drug-disease interaction with bromocriptine?

    <p>Exacerbation of peripheral vascular disease.</p> Signup and view all the answers

    Which statement about the effects of dopamine receptor agonists is correct?

    <p>Over time, they may cause more neuropsychiatric issues than levodopa monotherapy.</p> Signup and view all the answers

    Which medication is taken orally as a dopamine receptor agonist?

    <p>Pramipexole</p> Signup and view all the answers

    What is a common side effect of deprenyl?

    <p>Insomnia if administered too late in the day.</p> Signup and view all the answers

    What is the physiological effect of D1 receptor stimulation in renal blood vessels?

    <p>Increases sodium excretion</p> Signup and view all the answers

    What phenomenon describes the gradual fading of improvement from levodopa medication before the next dose?

    <p>Wear-off phenomenon</p> Signup and view all the answers

    How can high protein diets affect the absorption of L-dopa?

    <p>Decrease absorption of L-dopa</p> Signup and view all the answers

    Which strategy can not help overcome the on-off phenomenon of levodopa?

    <p>Taking levodopa with high-protein food</p> Signup and view all the answers

    What effect does Vitamin B6 (pyridoxine) have on the efficacy of L-dopa?

    <p>Enhances peripheral conversion of L-dopa to dopamine</p> Signup and view all the answers

    What is a potential risk of combining levodopa with nonselective MAO inhibitors?

    <p>Hypertensive crisis</p> Signup and view all the answers

    Which side effect may occur in patients taking anti-psychotics that block D2 receptors?

    <p>Parkinsonian syndrome</p> Signup and view all the answers

    What condition should cardiac patients be monitored for when using dopaminergic drugs?

    <p>Cardiac arrhythmias</p> Signup and view all the answers

    Study Notes

    Drugs Affecting the Central Nervous System

    • Neurodegenerative diseases involve neuronal damage in specific brain areas.
    • Neuronal damage is caused by excitotoxicity (excess glutamate acting on NMDA receptors), stroke, head trauma, oxidative stress (free radicals like OH), and apoptosis (programmed cell death).
    • Neurodegenerative diseases like Parkinson's, Alzheimer's, Huntington's, and Multiple sclerosis are challenging to treat due to the inability of CNS neurons to regenerate once damaged. Treatment focuses on symptom management rather than disease progression.

    Antiparkinsonian Drugs

    • Dopamine (DA) is a precursor to norepinephrine and a neurotransmitter in major dopaminergic pathways (nigrostriatal, mesolimbic-mesocortical, tuberoinfundibular, and chemoreceptor trigger zone).
    • The nigrostriatal pathway regulates movement (kinesis).
    • The mesolimbic-mesocortical pathway regulates cognitive functions and sensory perceptions.
    • The tuberoinfundibular pathway regulates prolactin.
    • Dopamine pathways in the brain's substantia nigra are damaged in Parkinson's disease.

    Parkinson's Disease

    • Parkinson's Disease (PD) is a progressive neurological disorder affecting muscle movement, characterized by four cardinal motor features: bradykinesia (slow movement), rigidity, resting tremor, and abnormal posture/gait (shuffling gait).
    • Non-motor symptoms include depression, dementia, and sleep disturbances.
    • PD most commonly affects individuals over 65.
    • The etiology involves a balance imbalance between inhibitory dopaminergic (DA) neurons and excitatory cholinergic (Ach) neurons.

    Classification of Parkinson's Disease

    • Primary (Idiopathic) PD: Degeneration of greater than 80% of DA neurons, often linked to oxidative stress and aging.
    • Secondary (Atypical) PD has multiple causes: Vascular Parkinsonism caused by multiple small strokes affecting movement control areas, Post-Traumatic Parkinsonism (repeated head injuries), Toxin-induced Parkinsonism (exposure to certain toxins), Infectious Parkinsonism (brain infections), and Drug-induced Parkinsonism (use of dopamine blockers, such as antipsychotics).

    Treatment for Parkinson's Disease

    • The goal of treatment is to increase DA and decrease Ach.

    • Dopaminergic drugs and anticholinergic drugs are used.

      • Dopamine receptor agonists also help.
      • Levodopa (L-dopa), a dopamine precursor, is the most commonly used treatment.
      • Large doses of Levodopa are needed, but most is converted to dopamine in the periphery and not the brain causing unwanted effects.
      • Carbidopa is added to levodopa to decrease peripheral conversion.
      • Entacapone and Tolcapone are COMT inhibitors that increase the availability of levodopa to the CNS.
    • Anticholinergic drugs (Benztropine, Trihexyphenidyl, procyclidine,) reduce Ach effects, but primarily treat tremor and rigidity.

    Adverse Effects of Levodopa

    • Central adverse effects include dyskinesias (involuntary movements) potentially occurring within 4-10 years after treatment start due to dopamine receptor overstimulation.
    • Central adverse effects also include psychosis (delusions, hallucinations, mood changes, anxiety). Low doses of certain atypical antipsychotics can be helpful in this instance.
    • Peripheral effects can include nausea, vomiting, postural hypotension, and brown saliva, sweat, and urine, due to higher levels of dopamine in the body. Wearing-off phenomenon (end-of-dose deterioration) occurs because symptomatic improvement from a levodopa dose wears off between doses. This can be mitigated through more frequent administrations, sustained release formulations or combination treatments.
    • High protein foods decrease L-dopa absorption. L-dopa absorption can improved by taking it 30 minutes before a meal.
    • Fluctuations in plasma concentrations of levodopa create "on-off" periods, where the symptoms return. This can be mitigated through adjustments to medication dosing or by adding other medications.
    • Levodopa interacts with other drugs including vitamin B6,MAOIs and antipsychotics.
    • Amantadine is an antiviral that also increases dopamine release and is used as an adjunct to levodopa.

    Dopamine Receptor Agonists

    • Dopamine receptor agonists stimulate dopamine receptors, and their use is effective in patients who do not respond to levodopa as they reduce motor fluctuations and dyskinesias. These may be less effective than levodopa alone, but are better tolerated in the long term.
    • Bromocriptine is an ergot-derived dopamine receptor agonist. A serious side effect is worsening of peripherial vascular disease from alpha receptor and serotonin receptor stimulation..
    • Non-ergot drugs (Apomorphine,Pramipexole, Ropinirole and Rotigotine) have slightly different side effect profiles and usages, and are usually taken orally or by patch.

    MAO-B Inhibitors (Selegiline and Rasagiline)

    • These drugs inhibit MAO-B; a critical enzyme for dopamine metabolism. They have a free radical scavenging effect, preserving DA neurons in brain tissue and increasing L-dopa effects, thus reducing the dosage required.
    • Selegiline can be metabolized to amphetamine or methamphetamine, which can cause insomnia or anxiety.
    • Rasagiline does not have this side effect. It is more potent and can be used in early stages of Parkinson's.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    Test your knowledge on the mechanisms and side effects of key medications in Parkinson's disease treatment. This quiz covers Amantadine, anticholinergics, and Rasagiline, focusing on their efficacy and associated risks. Perfect for students and professionals in medical and health fields.

    More Like This

    Pharmacology: Amantadine
    120 questions

    Pharmacology: Amantadine

    WellBacklitAppleTree avatar
    WellBacklitAppleTree
    Amantadine Pharmacology Flashcards
    6 questions
    Use Quizgecko on...
    Browser
    Browser